Related Experiment Video
Updated: Jul 3, 2026
09:22
In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein
Published on: January 2, 2015
Tau aggregates: toxic, inert, or protective species?
Alexis Bretteville1, Emmanuel Planel
1Columbia University Medical Center, Taub Institute for Research on Alzheimer's Disease and the Aging Brain, New York, NY 10032, USA.
Journal of Alzheimer'S Disease : JAD
|August 9, 2008
Summary
Investigating Alzheimer's disease, this study examines the controversial role of aggregated tau protein in neurodegeneration. It reviews tau aggregation, its different species, and their potential toxicity in the brain.
Area of Science:
- Neuroscience
- Biochemistry
- Pathology
Background:
- Alzheimer's disease brains exhibit amyloid-beta plaques and neurofibrillary tangles.
- Neurofibrillary tangles are composed of aggregated hyperphosphorylated tau protein.
- The precise role of aggregated tau in neurodegeneration remains debated, with evidence suggesting both toxic and protective functions.
Purpose of the Study:
- To examine tau aggregation and its potential roles in Alzheimer's disease pathogenesis.
- To review current findings on various tau species and their neurotoxic potential.
Main Methods:
- Literature review and analysis of existing research on tau protein.
- Examination of biochemical and pathological studies related to tau aggregation.
- Synthesis of evidence regarding the dual role of tau in neurodegeneration.
Main Results:
- Tau aggregation into neurofibrillary tangles is a hallmark of Alzheimer's disease.
- Different species and conformations of aggregated tau may exert distinct effects.
- Evidence supports both neurotoxic and potentially neuroprotective roles for aggregated tau.
Conclusions:
- The function of aggregated tau in Alzheimer's disease is complex and context-dependent.
- Further research is needed to elucidate the specific mechanisms by which tau species contribute to or mitigate neurodegeneration.
- Understanding tau's multifaceted role is crucial for developing targeted Alzheimer's therapies.
Related Concept Videos
01:23Toxicity Testing in Animals
Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...
01:24Drug Toxicity: Dose-Dependent Reactions
Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
01:26Physical Properties of Amines
Amines with low molecular weight are usually gaseous at room temperature, while those with high molecular weight are liquid or solids in nature. Usually, low molecular weight amines have a rotten fish-like smell. Diamines typically have a pungent smell. For instance, cadaverine and putrescine, depicted in Figure 1, are two molecules responsible for decaying tissue.
01:00Drug Toxicity: Overview
Drug toxicity quantifies the harm a compound causes to an organism, varying by dose and potentially impacting whole systems or specific organs like the liver. Toxic reactions may arise from venomous insect or spider bites, with effects ranging from mild symptoms to severe outcomes such as brain damage or death. Common forms of acute poisoning include ethanol intoxication and overdose of pain or fever medications, with substances like GHB and heroin being particularly lethal at doses close to...
01:26Toxic Reactions: Overview
When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
01:17Antidotes
Antidotes are medicinal substances used to counteract the harmful effects of toxins or drugs in the body. They function in various ways, each uniquely designed to combat specific toxic compounds.
Specific antidotes operate by inhibiting the enzymes that control biochemical pathways, reducing the production of harmful metabolites.
An example of an antidote is atropine, which counteracts the detrimental effects of cholinesterase inhibitors. It achieves this by deactivating muscarinic receptors,...
Specific antidotes operate by inhibiting the enzymes that control biochemical pathways, reducing the production of harmful metabolites.
An example of an antidote is atropine, which counteracts the detrimental effects of cholinesterase inhibitors. It achieves this by deactivating muscarinic receptors,...